Caribou Biosciences Valuation
| CRBU Stock | USD 2.02 0.04 2.02% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Caribou Biosciences shows a prevailing Real Value of $7.39 per share. The current price of the firm is $2.02. Our model approximates the value of Caribou Biosciences from analyzing the firm fundamentals such as Return On Equity of -0.44, operating margin of (16.67) %, and Shares Outstanding of 90.55 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Caribou Biosciences' valuation include:
Price Book 0.6505 | Enterprise Value -18.6 M | Enterprise Value Ebitda (36.94) | Price Sales 15.9404 | Enterprise Value Revenue 112.7254 |
Undervalued
Today
Please note that Caribou Biosciences' price fluctuation is slightly risky at this time. Calculation of the real value of Caribou Biosciences is based on 3 months time horizon. Increasing Caribou Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Caribou Biosciences' intrinsic value may or may not be the same as its current market price of 2.02, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.02 | Real 7.39 | Target 23.71 | Hype 2.02 | Naive 1.53 |
The intrinsic value of Caribou Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Caribou Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Caribou Biosciences helps investors to forecast how Caribou stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Caribou Biosciences more accurately as focusing exclusively on Caribou Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Caribou Biosciences' intrinsic value based on its ongoing forecasts of Caribou Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Caribou Biosciences' closest peers.
Caribou Biosciences Cash |
|
Caribou Valuation Trend
Caribou Biosciences' real value is important for investors to make better decisions and a more accurate overall view of Caribou Biosciences' financial worth over time. Using both Caribou Biosciences' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Caribou Biosciences Total Value Analysis
Caribou Biosciences is currently forecasted to have valuation of (18.62 M) with market capitalization of 182.92 M, debt of 27.11 M, and cash on hands of 339.92 M. The negative valuation of Caribou Biosciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Caribou Biosciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(18.62 M) | 182.92 M | 27.11 M | 339.92 M |
Caribou Biosciences Investor Information
About 63.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Caribou Biosciences has Price/Earnings To Growth (PEG) ratio of 0.5. The entity recorded a loss per share of 1.66. The firm had not issued any dividends in recent years. Based on the key indicators related to Caribou Biosciences' liquidity, profitability, solvency, and operating efficiency, Caribou Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Caribou Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Caribou Biosciences has an asset utilization ratio of 7.98 percent. This implies that the Company is making $0.0798 for each dollar of assets. An increasing asset utilization means that Caribou Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Caribou Biosciences Ownership Allocation
Caribou Biosciences holds a total of 90.55 Million outstanding shares. Over half of Caribou Biosciences' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Caribou Biosciences Profitability Analysis
The company reported the previous year's revenue of 34.48 M. Net Loss for the year was (102.07 M) with loss before overhead, payroll, taxes, and interest of (68.38 M).About Caribou Biosciences Valuation
The stock valuation mechanism determines Caribou Biosciences' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Caribou Biosciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Caribou Biosciences. We calculate exposure to Caribou Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Caribou Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -77.6 M | -73.7 M | |
| Pretax Profit Margin | (2.95) | (3.10) | |
| Operating Profit Margin | (3.37) | (3.53) | |
| Net Loss | (2.96) | (3.11) | |
| Gross Profit Margin | (2.25) | (2.14) |
Caribou Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Caribou Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 73.8 M |
Caribou Biosciences Current Valuation Indicators
Caribou Biosciences' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Caribou Biosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Caribou Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Caribou Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Caribou Biosciences' worth.Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.